Search research articles
Contact Us
Filters
Showing results (41-50 of 247) with videos related to
Page
of 25
Sort By:
Diabetes Care
|
August 29, 2006
Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy
Bruce A Perkins, Jaspreet Grewal, Eduardo Ng, et al.
Current Diabetes Reviews
|
September 7, 2021
Omega-3 Nutrition Therapy for the Treatment of Diabetic Sensorimotor Polyneuropathy
Deepak Menon, Evan J H Lewis, Bruce A Perkins, et al.
Canadian Journal of Diabetes
|
September 17, 2023
Factors Associated With Attainment of Glycemic Targets Among Adults With Type 1 and Type 2 Diabetes in Canada: A Cross-sectional Study Using Primary and Specialty Care Electronic Medical Record Data
Alanna Weisman, Ruth Brown, Lisa Chu, et al.
Diabetes Research and Clinical Practice
|
January 14, 2011
How sensitive is the case definition for diabetic sensorimotor polyneuropathy to the use of different symptoms, signs, and nerve conduction parameters in type 1 diabetes?
Tae Maen Shin, Vera Bril, Andrej Orszag, et al.
Journal of Psychosomatic Research
|
September 24, 2009
The consequences of anxious temperament for disease detection, self-management behavior, and quality of life in Type 2 diabetes mellitus
Peter A Hall, Gary M Rodin, T Michael Vallis, et al.
Diabetes Care
|
January 31, 2006
Objective evidence for the reversibility of nerve injury in diabetic neuropathic cachexia
Jaspreet Grewal, Vera Bril, Gary F Lewis, et al.
Journal of Diabetes and Its Complications
|
March 21, 2022
Orthostatic blood pressure changes and diabetes duration
Juan F Idiaquez Rios, Leif Erik Lovblom, Bruce A Perkins, et al.
The Lancet. Diabetes & Endocrinology
|
May 24, 2017
Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials
Alanna Weisman, Johnny-Wei Bai, Marina Cardinez, et al.
Canadian Journal of Diabetes
|
November 14, 2016
Can the Combination of Incretin Agents and Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors Reconcile the Yin and Yang of Glucagon?
Ronald M Goldenberg, Subodh Verma, Bruce A Perkins, et al.
Plos One
|
August 8, 2012
Evaluation of proxy tests for SFSN: evidence for mixed small and large fiber dysfunction
Hamid Ebadi, Bruce A Perkins, Hans D Katzberg, et al.
Page
of 25
Search research articles
Search
Showing results (41-50 of 247) with videos related to
Sort By:
Page
of 25
Diabetes Care
|
August 29, 2006
Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy
Bruce A Perkins, Jaspreet Grewal, Eduardo Ng, et al.
Current Diabetes Reviews
|
September 7, 2021
Omega-3 Nutrition Therapy for the Treatment of Diabetic Sensorimotor Polyneuropathy
Deepak Menon, Evan J H Lewis, Bruce A Perkins, et al.
Canadian Journal of Diabetes
|
September 17, 2023
Factors Associated With Attainment of Glycemic Targets Among Adults With Type 1 and Type 2 Diabetes in Canada: A Cross-sectional Study Using Primary and Specialty Care Electronic Medical Record Data
Alanna Weisman, Ruth Brown, Lisa Chu, et al.
Diabetes Research and Clinical Practice
|
January 14, 2011
How sensitive is the case definition for diabetic sensorimotor polyneuropathy to the use of different symptoms, signs, and nerve conduction parameters in type 1 diabetes?
Tae Maen Shin, Vera Bril, Andrej Orszag, et al.
Journal of Psychosomatic Research
|
September 24, 2009
The consequences of anxious temperament for disease detection, self-management behavior, and quality of life in Type 2 diabetes mellitus
Peter A Hall, Gary M Rodin, T Michael Vallis, et al.
Diabetes Care
|
January 31, 2006
Objective evidence for the reversibility of nerve injury in diabetic neuropathic cachexia
Jaspreet Grewal, Vera Bril, Gary F Lewis, et al.
Journal of Diabetes and Its Complications
|
March 21, 2022
Orthostatic blood pressure changes and diabetes duration
Juan F Idiaquez Rios, Leif Erik Lovblom, Bruce A Perkins, et al.
The Lancet. Diabetes & Endocrinology
|
May 24, 2017
Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials
Alanna Weisman, Johnny-Wei Bai, Marina Cardinez, et al.
Canadian Journal of Diabetes
|
November 14, 2016
Can the Combination of Incretin Agents and Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors Reconcile the Yin and Yang of Glucagon?
Ronald M Goldenberg, Subodh Verma, Bruce A Perkins, et al.
Plos One
|
August 8, 2012
Evaluation of proxy tests for SFSN: evidence for mixed small and large fiber dysfunction
Hamid Ebadi, Bruce A Perkins, Hans D Katzberg, et al.
Page
of 25